Literature DB >> 15639119

Deletion of the LMNA initiator codon leading to a neurogenic variant of autosomal dominant Emery-Dreifuss muscular dystrophy.

Maggie C Walter1, Thomas N Witt, Beate Schlotter Weigel, Peter Reilich, Pascale Richard, Dieter Pongratz, Gisèle Bonne, Manfred S Wehnert, Hanns Lochmüller.   

Abstract

Mutations in the LMNA gene encoding the nuclear envelope protein, lamins A and C, have been associated with at least nine distinct disorders now called laminopathies, including Emery-Dreifuss muscular dystrophy and Charcot-Marie-Tooth type 2 disease. We identified a novel mutation in the 5' region of the LMNA gene -3del15, resulting in the loss of 15 nucleotides from -3 to +12, including the translation ATG initiator codon. The mutation segregates in a previously described family with a clinical phenotype that shared features of both Emery-Dreifuss muscular dystrophy and Charcot-Marie-Tooth type 2. Thus, the mutation with this unique phenotypical expression represents the first example for a link between the neurogenic and myogenic phenotypes and extends the clinical variability of laminopathies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15639119     DOI: 10.1016/j.nmd.2004.09.007

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  14 in total

Review 1.  Inner nuclear membrane proteins: impact on human disease.

Authors:  Iván Méndez-López; Howard J Worman
Journal:  Chromosoma       Date:  2012-02-04       Impact factor: 4.316

2.  Molecular genetic analysis of the nested Drosophila melanogaster lamin C gene.

Authors:  Sandra R Schulze; Beatrice Curio-Penny; Yuhong Li; Reza A Imani; Lena Rydberg; Pamela K Geyer; Lori L Wallrath
Journal:  Genetics       Date:  2005-06-18       Impact factor: 4.562

Review 3.  Laminopathies and the long strange trip from basic cell biology to therapy.

Authors:  Howard J Worman; Loren G Fong; Antoine Muchir; Stephen G Young
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

Review 4.  The nuclear envelope: an intriguing focal point for neurogenetic disease.

Authors:  Howard J Worman; William T Dauer
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

5.  Blocking farnesylation of the prelamin A variant in Hutchinson-Gilford progeria syndrome alters the distribution of A-type lamins.

Authors:  Yuexia Wang; Cecilia Ostlund; Jason C Choi; Theresa C Swayne; Gregg G Gundersen; Howard J Worman
Journal:  Nucleus       Date:  2012-08-16       Impact factor: 4.197

6.  Partial LPL deletions: rare copy-number variants contributing towards severe hypertriglyceridemia.

Authors:  Jacqueline S Dron; Jian Wang; Adam D McIntyre; Henian Cao; John F Robinson; P Barton Duell; Priya Manjoo; James Feng; Irina Movsesyan; Mary J Malloy; Clive R Pullinger; John P Kane; Robert A Hegele
Journal:  J Lipid Res       Date:  2019-09-13       Impact factor: 5.922

7.  The role of Drosophila Lamin C in muscle function and gene expression.

Authors:  George Dialynas; Sean Speese; Vivian Budnik; Pamela K Geyer; Lori L Wallrath
Journal:  Development       Date:  2010-08-11       Impact factor: 6.868

Review 8.  "Laminopathies": a wide spectrum of human diseases.

Authors:  Howard J Worman; Gisèle Bonne
Journal:  Exp Cell Res       Date:  2007-03-30       Impact factor: 3.905

9.  Lamin A/C-mediated neuromuscular junction defects in Emery-Dreifuss muscular dystrophy.

Authors:  Alexandre Méjat; Valérie Decostre; Juan Li; Laure Renou; Akanchha Kesari; Daniel Hantaï; Colin L Stewart; Xiao Xiao; Eric Hoffman; Gisèle Bonne; Tom Misteli
Journal:  J Cell Biol       Date:  2009-01-05       Impact factor: 10.539

10.  A comparative study of Drosophila and human A-type lamins.

Authors:  Sandra R Schulze; Beatrice Curio-Penny; Sean Speese; George Dialynas; Diane E Cryderman; Caitrin W McDonough; Demet Nalbant; Melissa Petersen; Vivian Budnik; Pamela K Geyer; Lori L Wallrath
Journal:  PLoS One       Date:  2009-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.